Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart ablation system aims to simplify AFib treatment
Disease control Not yet recruitingThis study tests a new pulsed field ablation system (VARIPULSE catheter and TRUPULSE generator) with updated software in 50 adults with persistent atrial fibrillation (an irregular heart rhythm lasting over 7 days). The goal is to see how well the system works during the procedur…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New heart catheter aims to tame stubborn AFib
Disease control Not yet recruitingThis study tests a new device called the VARIPULSE catheter for people with a type of irregular heartbeat called persistent atrial fibrillation. The procedure uses heat energy to isolate certain veins in the heart to restore normal rhythm. The trial will check how safe the device…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC